Cargando…
Propranolol exhibits activity against hemangiomas independent of beta blockade
Propranolol is a widely used beta blocker that consists of a racemic mixture of R and S stereoisomers. Only the S stereoisomer has significant activity against the beta-adrenergic receptor. A fortuitous clinical observation was made in an infant who received propranolol for cardiac disease, and regr...
Autores principales: | Sasaki, Maiko, North, Paula E., Elsey, Justin, Bubley, Jeffrey, Rao, Shikha, Jung, Yoonhee, Wu, Shengnan, Zou, Ming-Hui, Pollack, Brian P., Kumar, Jayanth, Singh, Hartej, Arbiser, Jack L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825155/ https://www.ncbi.nlm.nih.gov/pubmed/31701018 http://dx.doi.org/10.1038/s41698-019-0099-9 |
Ejemplares similares
-
Palladium based nanoparticles for the treatment of advanced melanoma
por: Elsey, Justin, et al.
Publicado: (2019) -
Role of propranolol in hemangiomas
por: Gajbhiye, Vishal, et al.
Publicado: (2011) -
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012) -
Severe hypoglycemia in propranolol treatment for infantile hemangiomas
por: Morimoto, Akira, et al.
Publicado: (2022) -
Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013)